CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
736-750 of 921
Pediatric Narcolepsy: Psychological and Social Comorbidities
MinuteCE®Pediatric Narcolepsy: Psychological and Social Comorbidities
Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
MinuteCE®Current Pharmacologic Approaches to Managing Pediatric Narcolepsy
Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Once-Nightly Sodium Oxybate
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
MinuteCE®Can We Talk? Optimizing Patient and Parent/Caregiver Buy-in to the Management of Pediatric Narcolepsy
Implementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
CME/CEImplementing a Successful Barostim Program in the Clinic: Best Practices and Real World Experience
- advertisement
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
CME/CEStrategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice
Making the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
CME/CEMaking the Case for Dual Ang-2/VEGF-A Inhibition: Anatomical Benefits
Getting to the Root of CKD-Associated Pruritus: Questions From the Field
CME/CEGetting to the Root of CKD-Associated Pruritus: Questions From the Field
Overcoming Clinical Inertia in Hyperkalemia Management
CME/CEOvercoming Clinical Inertia in Hyperkalemia Management
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CEDuchenne Muscular Dystrophy: Differentiating Advances in Treatment
Making the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
CME/CEMaking the Case for Dual Ang-2 VEGF-A Inhibition: Durability and Drying
- advertisement
Beyond BeAT-HF: Integrating Barostim into a Comprehensive HF Program
CME/CEBeyond BeAT-HF: Integrating Barostim into a Comprehensive HF Program
Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
CME/CEApplying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
